Mason Street Advisors’s Usana Health Sciences USNA Stock Holding History

Mason Street Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,472	Closed	-$345K	–	1193
2020 Q4	$345K	Sell	4,472 -22	-0.5%	-$1.7K	0.01%	1283
2020 Q3	$331K	Sell	4,494 -82	-2%	-$6.58K	0.01%	1213
2020 Q2	$336K	Buy	4,576 +204	+5%	+$16K	0.01%	1204
2020 Q1	$253K	Hold	4,372	–	–	0.01%	1210
2019 Q4	$343K	Sell	4,372 -11	-0.3%	-$810	0.01%	1244
2019 Q3	$300K	Sell	4,383 -56	-1%	-$3.76K	0.01%	1257
2019 Q2	$353K	Buy	+4,439	New	+$352K	0.01%	1204

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Mason Street Advisors's USNA Position: Q1 2021 in Review

Mason Street Advisors sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 4,472 shares — an estimated $345K sold.

Mason Street Advisors first reported a position in USNA in Q2 2019 and held it in 7 quarters. The position peaked at $353K in Q2 2019. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

Mason Street Advisors reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
Mason Street Advisors sold 4,472 Usana Health Sciences shares in Q1 2021, an estimated $345K.
Mason Street Advisors first reported a position in Usana Health Sciences in Q2 2019 and held it in 7 quarters.
Mason Street Advisors's Usana Health Sciences position peaked at $353K in Q2 2019.
198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.